caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1467741306

Matthen MathewM.D.

Hematology-OncologyBoca Raton, FLI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Matthen Mathew's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 2 outbound destinations.

Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
MOUNT SINAI HOSPITAL1532
TRANSCARE NEW YORK, INC.1122
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
272
Beneficiaries
—
Total drug cost
$1.7M
Distinct drugs
9
Brand share
59.6%
Top prescribed drugs
Osimertinib Mesylate73 claims
Prednisone55 claims
Sotorasib32 claims
Apixaban32 claims
Acyclovir24 claims
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
77.6
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$475
Payment records
17
By payment type
Food and Beverage$475
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,136
Unique beneficiaries
—
Total services
2,797
Distinct HCPCS
8
Medicare payment
$156K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 737 Hematology-Oncology providers in FL — above median (cohort median 1,932).